Key Insights
The Vietnamese diabetes care devices market, valued at $424.10 million in 2025, is projected to experience steady growth, driven by rising diabetes prevalence, increasing healthcare expenditure, and growing awareness of effective diabetes management. The Compound Annual Growth Rate (CAGR) of 2.10% from 2025 to 2033 indicates a consistent, albeit moderate, expansion. This growth is fueled by several key factors: the increasing adoption of advanced monitoring technologies like continuous glucose monitoring (CGM) systems, a shift towards convenient insulin delivery methods such as insulin pumps and pens, and expanding government initiatives focused on improving diabetes care access. Market segmentation reveals a significant share held by monitoring devices (self-monitoring blood glucose devices and CGM systems), followed by lancets and management devices (insulin pumps, infusion sets, and insulin delivery systems). Key players like Roche, Abbott, Medtronic, and Novo Nordisk are actively competing in this market, offering innovative products and expanding their distribution networks to cater to the growing demand. The market faces challenges including affordability constraints for certain segments of the population and the need for continuous patient education to ensure proper device utilization.
Despite a moderate CAGR, the Vietnamese diabetes care devices market presents considerable opportunities for growth. The ongoing expansion of private healthcare insurance coverage is likely to boost market penetration, as will increased public health campaigns promoting early diagnosis and self-management of diabetes. Further growth can be anticipated from the increasing availability of technologically advanced, user-friendly devices and the emergence of digital health solutions that facilitate remote patient monitoring and data management. This translates to a promising long-term outlook, with continued market expansion propelled by a combination of demographic shifts, technological advancements, and focused government support within the healthcare sector. However, sustainable growth requires addressing affordability concerns and ensuring widespread access to quality diabetes care across all regions of Vietnam.
This comprehensive report provides a detailed analysis of the Diabetes Care Devices industry in Vietnam, covering the period 2019-2033. It offers invaluable insights for industry professionals, investors, and strategic decision-makers seeking to understand the market dynamics, growth trends, and future opportunities within this vital sector. The report utilizes a robust methodology incorporating historical data (2019-2024), a base year of 2025, and forecasts extending to 2033. The analysis is segmented by key device categories, including monitoring and management devices, providing a granular understanding of the Vietnamese market.
Diabetes Care Devices Industry in Vietnam Market Dynamics & Structure
The Vietnamese diabetes care devices market exhibits a moderately concentrated structure, with key players like Roche, Abbott, Medtronic, and Novo Nordisk holding significant market share. However, the market is also witnessing the entry of new players and increased competition, particularly in the self-monitoring blood glucose (SMBG) segment. Technological innovation, driven by advancements in continuous glucose monitoring (CGM) and insulin pump technology, is a significant growth driver. The regulatory framework, while evolving, plays a key role in shaping market access and adoption. The increasing prevalence of diabetes, coupled with rising healthcare expenditure, fuels demand. Furthermore, the availability of affordable generic insulin and devices is impacting market dynamics.
- Market Concentration: The top 7 companies hold approximately xx% of the market share in 2025.
- Technological Innovation: CGM systems and advanced insulin pumps are driving premiumization and market expansion.
- Regulatory Framework: Government initiatives to improve diabetes management are creating opportunities for market growth.
- Competitive Landscape: Intense competition among established and emerging players is expected to continue.
- M&A Activity: The number of M&A deals in the period 2019-2024 was xx, primarily focused on consolidating market share and enhancing technological capabilities. (Prediction: xx deals in 2025-2033)
- End-User Demographics: The growing elderly population and increasing prevalence of diabetes are key demographic drivers.
Diabetes Care Devices Industry in Vietnam Growth Trends & Insights
The Vietnamese diabetes care devices market is projected to experience robust growth over the forecast period (2025-2033). Driven by rising diabetes prevalence, increasing awareness, and improving healthcare infrastructure, the market size is estimated to reach xx million units by 2033, exhibiting a CAGR of xx% from 2025. The adoption rate of advanced technologies like CGM is steadily increasing, though affordability remains a barrier for a substantial segment of the population. Consumer behavior is shifting towards preference for convenient, user-friendly devices with improved accuracy and data connectivity. Government initiatives and public health campaigns play a crucial role in influencing market adoption. The historical period (2019-2024) showed an average annual growth of xx million units, reflecting early adoption of new technologies and increasing awareness.
Dominant Regions, Countries, or Segments in Diabetes Care Devices Industry in Vietnam
The urban areas of Vietnam, particularly Ho Chi Minh City and Hanoi, are currently the leading regions for diabetes care device adoption due to higher healthcare infrastructure and spending. Among the segments, the Self-monitoring Blood Glucose Devices (SMBG) segment holds the largest market share, followed by insulin syringes and disposable pens.
- Key Drivers:
- Rising prevalence of diabetes in urban areas.
- Increased healthcare expenditure and insurance coverage.
- Improved access to healthcare facilities.
- Dominance Factors:
- Higher disposable incomes in urban centers.
- Greater awareness and understanding of diabetes management.
- Availability of a wider range of products and services.
- Growth Potential: The rural areas present significant untapped potential, although infrastructure and affordability constraints remain challenges.
Diabetes Care Devices Industry in Vietnam Product Landscape
The Vietnamese market offers a diverse range of diabetes care devices, from basic SMBG systems to advanced CGM and insulin pump technologies. Innovations focus on improving accuracy, ease of use, data connectivity, and integration with smart devices. CGM systems are increasingly gaining popularity due to their real-time glucose monitoring capabilities, while insulin pumps offer improved glycemic control for patients requiring insulin therapy. The introduction of user-friendly features, such as smaller device sizes and intuitive interfaces, drives product adoption.
Key Drivers, Barriers & Challenges in Diabetes Care Devices Industry in Vietnam
Key Drivers:
- Rising prevalence of diabetes.
- Increased government initiatives and healthcare spending.
- Growing awareness among the population regarding diabetes management.
- Technological advancements leading to improved device accuracy and user experience.
Key Challenges:
- High cost of advanced devices limiting affordability, particularly in rural areas.
- Limited access to healthcare infrastructure, especially in remote regions.
- Potential supply chain disruptions impacting availability.
- Stringent regulatory approvals for new devices posing market entry barriers.
Emerging Opportunities in Diabetes Care Devices Industry in Vietnam
- Expansion into rural markets with cost-effective solutions.
- Development of integrated digital health platforms linking devices, data analytics, and telehealth services.
- Focus on personalized diabetes management based on individual needs and preferences.
- Leveraging mobile technology for remote monitoring and patient support.
Growth Accelerators in the Diabetes Care Devices Industry in Vietnam Industry
Strategic collaborations between multinational companies and local distributors are crucial for market penetration. Technological breakthroughs, specifically in CGM and insulin pump technologies, coupled with enhanced data analytics capabilities, offer significant growth potential. Government policies promoting affordable access to diabetes care devices further accelerate market expansion.
Key Players Shaping the Diabetes Care Devices Industry in Vietnam Market
- Roche
- Dexcom
- Ypsomed
- Abbott
- Eli Lilly
- Sanofi
- Medtronic
- Tandem
- Insulet
- Lifescan (Johnson & Johnson)
- Becton and Dickenson
- Novo Nordisk
Notable Milestones in Diabetes Care Devices Industry in Vietnam Sector
- May 2023: Partnership between VPA and Roche Diabetes Care Vietnam to improve healthcare access for children with Type 1 diabetes.
- January 2022: 'Gestational Diabetes in Vietnam' project launched to investigate GDM prevalence and management.
- March 2021: Abbott Vietnam introduces the FreeStyle Libre system.
In-Depth Diabetes Care Devices Industry in Vietnam Market Outlook
The Vietnamese diabetes care devices market is poised for sustained growth, driven by the convergence of rising diabetes prevalence, technological advancements, and supportive government policies. Strategic partnerships, focused innovation, and expansion into untapped markets present lucrative opportunities for both established and emerging players. The focus on improving affordability and access to quality devices in underserved areas will be critical for realizing the full market potential.
Diabetes Care Devices Industry in Vietnam Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Blood Glucose Monitoring
- 1.2.1. Sensors
- 1.2.2. Durables
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Insulin Cartridges
- 2.4. Disposable Pens
-
2.1. Insulin Pump
Diabetes Care Devices Industry in Vietnam Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Diabetes Care Devices Industry in Vietnam REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 2.10% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring
- 3.3. Market Restrains
- 3.3.1. Stringent Regulatory Procedures
- 3.4. Market Trends
- 3.4.1. Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Blood Glucose Monitoring
- 5.1.2.1. Sensors
- 5.1.2.2. Durables
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Insulin Cartridges
- 5.2.4. Disposable Pens
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. North America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Blood Glucose Monitoring
- 6.1.2.1. Sensors
- 6.1.2.2. Durables
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Insulin Cartridges
- 6.2.4. Disposable Pens
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. South America Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Blood Glucose Monitoring
- 7.1.2.1. Sensors
- 7.1.2.2. Durables
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Insulin Cartridges
- 7.2.4. Disposable Pens
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Europe Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Blood Glucose Monitoring
- 8.1.2.1. Sensors
- 8.1.2.2. Durables
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Insulin Cartridges
- 8.2.4. Disposable Pens
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Middle East & Africa Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Blood Glucose Monitoring
- 9.1.2.1. Sensors
- 9.1.2.2. Durables
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Insulin Cartridges
- 9.2.4. Disposable Pens
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. Asia Pacific Diabetes Care Devices Industry in Vietnam Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Blood Glucose Monitoring
- 10.1.2.1. Sensors
- 10.1.2.2. Durables
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Insulin Cartridges
- 10.2.4. Disposable Pens
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Roche
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom*List Not Exhaustive 7 2 Company Share Analysi
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Ypsomed
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Abbottt
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Medtronic
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Tandem
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Insulet
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Lifescan (Johnson &Johnson)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Becton and Dickenson
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Novo Nordisk
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Roche
List of Figures
- Figure 1: Global Diabetes Care Devices Industry in Vietnam Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Vietnam Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 3: Vietnam Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 4: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 5: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 6: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 7: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 8: North America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 9: North America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 11: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 12: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 13: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 14: South America Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 15: South America Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 16: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 17: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 18: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 19: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 20: Europe Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 21: Europe Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 22: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 23: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 24: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 25: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 26: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 27: Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Monitoring Devices 2024 & 2032
- Figure 29: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Monitoring Devices 2024 & 2032
- Figure 30: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Management Devices 2024 & 2032
- Figure 31: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Management Devices 2024 & 2032
- Figure 32: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million), by Country 2024 & 2032
- Figure 33: Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 7: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 8: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 9: United States Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Canada Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Mexico Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 13: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 14: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 15: Brazil Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Argentina Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Rest of South America Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 19: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 20: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 21: United Kingdom Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Germany Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: France Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Italy Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Spain Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Russia Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Benelux Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Nordics Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 29: Rest of Europe Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 31: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 32: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 33: Turkey Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Israel Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 35: GCC Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: North Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: South Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Rest of Middle East & Africa Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 40: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 41: Global Diabetes Care Devices Industry in Vietnam Revenue Million Forecast, by Country 2019 & 2032
- Table 42: China Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 43: India Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Japan Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: South Korea Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: ASEAN Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Oceania Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Asia Pacific Diabetes Care Devices Industry in Vietnam Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Diabetes Care Devices Industry in Vietnam?
The projected CAGR is approximately 2.10%.
2. Which companies are prominent players in the Diabetes Care Devices Industry in Vietnam?
Key companies in the market include Roche, Dexcom*List Not Exhaustive 7 2 Company Share Analysi, Ypsomed, Abbottt, Eli Lilly, Sanofi, Medtronic, Tandem, Insulet, Lifescan (Johnson &Johnson), Becton and Dickenson, Novo Nordisk.
3. What are the main segments of the Diabetes Care Devices Industry in Vietnam?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 424.10 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Number of Preterm and Low-weight Births; Advanced Technology in Fetal and Prenatal Monitoring.
6. What are the notable trends driving market growth?
Management Devices Hold Highest Market Share in Vietnam Diabetes Care Devices Market.
7. Are there any restraints impacting market growth?
Stringent Regulatory Procedures.
8. Can you provide examples of recent developments in the market?
May 2023: The VPA and Roche Diabetes Care Vietnam, represented by Roche Vietnam Company Limited, have partnered to improve healthcare access for disadvantaged children with Type 1 diabetes in Vietnam as part of the global initiative CDiC. Led by Novo Nordisk and Roche Diabetes Care, this program aims to expand healthcare access and provide insulin and supplies to children and young individuals with Type 1 diabetes up to age 25 in countries with limited resources.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Diabetes Care Devices Industry in Vietnam," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Diabetes Care Devices Industry in Vietnam report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Diabetes Care Devices Industry in Vietnam?
To stay informed about further developments, trends, and reports in the Diabetes Care Devices Industry in Vietnam, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
